NO854305L - Fremgangsmaate ved fremstilling av indanderivater. - Google Patents
Fremgangsmaate ved fremstilling av indanderivater.Info
- Publication number
- NO854305L NO854305L NO854305A NO854305A NO854305L NO 854305 L NO854305 L NO 854305L NO 854305 A NO854305 A NO 854305A NO 854305 A NO854305 A NO 854305A NO 854305 L NO854305 L NO 854305L
- Authority
- NO
- Norway
- Prior art keywords
- group
- preparation
- halogen
- carbon atoms
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
- C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Catalysts (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848427125A GB8427125D0 (en) | 1984-10-26 | 1984-10-26 | Organic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO854305L true NO854305L (no) | 1986-04-28 |
| NO160075B NO160075B (no) | 1988-11-28 |
| NO160075C NO160075C (no) | 1989-03-08 |
Family
ID=10568794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO854305A NO160075C (no) | 1984-10-26 | 1985-10-28 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-piperazin-3-fenylindanderivater. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4684650A (no) |
| EP (1) | EP0183349B1 (no) |
| JP (1) | JPH0655718B2 (no) |
| AT (1) | ATE57182T1 (no) |
| AU (2) | AU595167B2 (no) |
| CA (1) | CA1247098A (no) |
| DE (1) | DE3580000D1 (no) |
| DK (1) | DK493485A (no) |
| ES (1) | ES8702402A1 (no) |
| FI (1) | FI84174C (no) |
| GB (1) | GB8427125D0 (no) |
| GR (1) | GR852586B (no) |
| IE (1) | IE58861B1 (no) |
| IL (1) | IL76538A (no) |
| NO (1) | NO160075C (no) |
| NZ (1) | NZ213577A (no) |
| PT (1) | PT81371B (no) |
| ZA (1) | ZA857341B (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| US5322851A (en) * | 1990-07-02 | 1994-06-21 | H. Lundbeck A/S | Indole derivatives |
| DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
| DK286990D0 (da) * | 1990-12-04 | 1990-12-04 | Lundbeck & Co As H | Indanderivater |
| US5643784A (en) * | 1990-12-04 | 1997-07-01 | H, Lundbeck A/S | Indan derivatives |
| NZ243065A (en) | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
| DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| US7122376B2 (en) * | 2001-11-01 | 2006-10-17 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US7049146B2 (en) * | 2000-11-14 | 2006-05-23 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US20040131504A1 (en) * | 2002-09-17 | 2004-07-08 | Landers James P. | Remote temperature sensing of small volume and related apparatus thereof |
| AU2012273657B2 (en) | 2011-06-20 | 2016-07-21 | H. Lundbeck A/S | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia |
| KR101893741B1 (ko) * | 2015-11-13 | 2018-08-30 | 도요보 가부시키가이샤 | 적층 폴리에스테르 필름 |
| EP3891134A1 (en) | 2018-12-03 | 2021-10-13 | H. Lundbeck A/S | Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU521110B2 (en) * | 1978-06-20 | 1982-03-18 | Synthelabo | Phenylpiperazine derivatives |
| IE50867B1 (en) * | 1980-02-29 | 1986-08-06 | Kefalas As | Indane derivatives |
-
1984
- 1984-10-26 GB GB848427125A patent/GB8427125D0/en active Pending
-
1985
- 1985-09-16 IE IE228585A patent/IE58861B1/en not_active IP Right Cessation
- 1985-09-23 NZ NZ213577A patent/NZ213577A/xx unknown
- 1985-09-24 ZA ZA857341A patent/ZA857341B/xx unknown
- 1985-09-24 AT AT85306782T patent/ATE57182T1/de active
- 1985-09-24 DE DE8585306782T patent/DE3580000D1/de not_active Expired - Fee Related
- 1985-09-24 EP EP85306782A patent/EP0183349B1/en not_active Expired - Lifetime
- 1985-10-01 IL IL76538A patent/IL76538A/xx not_active IP Right Cessation
- 1985-10-10 FI FI853951A patent/FI84174C/fi not_active IP Right Cessation
- 1985-10-10 US US06/786,199 patent/US4684650A/en not_active Expired - Fee Related
- 1985-10-11 CA CA000492870A patent/CA1247098A/en not_active Expired
- 1985-10-25 GR GR852586A patent/GR852586B/el unknown
- 1985-10-25 ES ES548204A patent/ES8702402A1/es not_active Expired
- 1985-10-25 DK DK493485A patent/DK493485A/da not_active Application Discontinuation
- 1985-10-25 AU AU49106/85A patent/AU595167B2/en not_active Ceased
- 1985-10-25 PT PT81371A patent/PT81371B/pt not_active IP Right Cessation
- 1985-10-26 JP JP60238621A patent/JPH0655718B2/ja not_active Expired - Lifetime
- 1985-10-28 NO NO854305A patent/NO160075C/no unknown
-
1990
- 1990-01-16 AU AU47965/90A patent/AU4796590A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GR852586B (no) | 1986-02-26 |
| FI84174C (fi) | 1991-10-25 |
| JPH0655718B2 (ja) | 1994-07-27 |
| PT81371A (en) | 1985-11-01 |
| EP0183349B1 (en) | 1990-10-03 |
| ZA857341B (en) | 1986-09-24 |
| IL76538A0 (en) | 1986-02-28 |
| FI84174B (fi) | 1991-07-15 |
| DE3580000D1 (de) | 1990-11-08 |
| CA1247098A (en) | 1988-12-20 |
| AU4796590A (en) | 1990-05-10 |
| AU595167B2 (en) | 1990-03-29 |
| FI853951L (fi) | 1986-04-27 |
| GB8427125D0 (en) | 1984-12-05 |
| AU4910685A (en) | 1986-05-01 |
| JPS61171466A (ja) | 1986-08-02 |
| EP0183349A1 (en) | 1986-06-04 |
| ES548204A0 (es) | 1987-01-01 |
| FI853951A0 (fi) | 1985-10-10 |
| NZ213577A (en) | 1988-11-29 |
| NO160075C (no) | 1989-03-08 |
| ATE57182T1 (de) | 1990-10-15 |
| NO160075B (no) | 1988-11-28 |
| IL76538A (en) | 1989-09-10 |
| PT81371B (pt) | 1987-11-11 |
| DK493485A (da) | 1986-04-27 |
| DK493485D0 (da) | 1985-10-25 |
| IE852285L (en) | 1986-04-26 |
| IE58861B1 (en) | 1993-11-17 |
| US4684650A (en) | 1987-08-04 |
| ES8702402A1 (es) | 1987-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES541557A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 8-cloro-1,5-benzotiazepina | |
| ES539446A0 (es) | Un procedimiento para preparar un derivado de dihidropiridazinona | |
| NO854305L (no) | Fremgangsmaate ved fremstilling av indanderivater. | |
| DE3777852D1 (de) | Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| ES557079A0 (es) | Un procedimiento para la preparacion de derivados de 1,5-benzotiazepina | |
| ES519530A0 (es) | Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas. | |
| DE69007203D1 (de) | Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel. | |
| SE8802192L (sv) | Forfarande for framstellning av kondenserade as-trizinderivat | |
| JPS54126732A (en) | Antidepressant containing 2-(3-aminopropoxy)diphenyl ether or its derivative | |
| JPS55154972A (en) | Hexahydro-1h-pyrido 4,3-b indole derivative | |
| FI852465L (fi) | Selektiva, biologiskt aktiva 7-oxo- prostacyklin-derivat samt framstaellningsfoerfarande foer dessa samt dessa innehaollande farmaceutiska kompositioner. |